Carrie L. Welch

8.6k total citations · 2 hit papers
64 papers, 6.3k citations indexed

About

Carrie L. Welch is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Carrie L. Welch has authored 64 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Surgery and 15 papers in Immunology. Recurrent topics in Carrie L. Welch's work include Cholesterol and Lipid Metabolism (19 papers), Peroxisome Proliferator-Activated Receptors (15 papers) and Drug Transport and Resistance Mechanisms (11 papers). Carrie L. Welch is often cited by papers focused on Cholesterol and Lipid Metabolism (19 papers), Peroxisome Proliferator-Activated Receptors (15 papers) and Drug Transport and Resistance Mechanisms (11 papers). Carrie L. Welch collaborates with scholars based in United States, Japan and Netherlands. Carrie L. Welch's co-authors include Alan R. Tall, Nan Wang, Laurent Yvan‐Charvet, Raymond L. Stallings, Seongah Han, Tamara A. Pagler, Mollie Ranalletta, Ira Tabas, Domenico Accili and Sandra Abramowicz and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Carrie L. Welch

63 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

2007 648 citations Carrie L. Welch, Raymond L. Stallings et al. Oncogene profile →
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation

2010 562 citations Laurent Yvan‐Charvet, Tamara A. Pagler et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carrie L. Welch United States	33	2.8k	2.2k	1.8k	1.4k	1.0k	64	6.3k
Marit Westerterp Netherlands	40	1.9k 0.7×	1.8k 0.8×	1.7k 0.9×	717 0.5×	946 0.9×	77	5.1k
Bernardo L. Trigatti Canada	34	2.4k 0.9×	2.8k 1.3×	927 0.5×	834 0.6×	884 0.9×	93	5.6k
Farhad Parhami United States	37	2.4k 0.8×	1.4k 0.6×	1.3k 0.7×	572 0.4×	684 0.7×	60	6.1k
Nicolas Duverger France	38	2.9k 1.0×	3.3k 1.5×	1.0k 0.6×	968 0.7×	661 0.6×	67	6.2k
Debbie Liao United States	15	4.2k 1.5×	1.1k 0.5×	1.4k 0.7×	1.7k 1.2×	858 0.8×	22	6.4k
Marcelo Amar United States	44	1.9k 0.7×	2.8k 1.2×	591 0.3×	829 0.6×	723 0.7×	85	5.2k
Thomas O. McDonald United States	27	1.4k 0.5×	1.1k 0.5×	1.2k 0.7×	682 0.5×	666 0.6×	62	4.3k
Bruno Esposito France	38	2.3k 0.8×	1.1k 0.5×	4.5k 2.4×	771 0.6×	1.6k 1.5×	72	8.0k
Gerald Höefler Austria	50	4.2k 1.5×	1.5k 0.7×	705 0.4×	2.3k 1.6×	909 0.9×	192	9.3k
Eva Hurt‐Camejo Sweden	42	1.8k 0.6×	1.5k 0.7×	1.2k 0.6×	908 0.7×	793 0.8×	92	4.8k

Countries citing papers authored by Carrie L. Welch

Since Specialization

Citations

This map shows the geographic impact of Carrie L. Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie L. Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie L. Welch more than expected).

Fields of papers citing papers by Carrie L. Welch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie L. Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie L. Welch. The network helps show where Carrie L. Welch may publish in the future.

Co-authorship network of co-authors of Carrie L. Welch

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie L. Welch. A scholar is included among the top collaborators of Carrie L. Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie L. Welch. Carrie L. Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eichstaedt, Christina A., Rajiv D. Machado, Stefan Gräf, et al.. (2025). Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar. Human Mutation. 2025(1). 2475635–2475635.

Teitel, David F., et al.. (2022). Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closer. Pulmonary Circulation. 12(1). e12033–e12033. 4 indexed citations

Welch, Carrie L. & Wendy K. Chung. (2020). Genetics and Other Omics in Pediatric Pulmonary Arterial Hypertension. CHEST Journal. 157(5). 1287–1295. 21 indexed citations

Zhu, Na, Michael W. Pauciulo, Carrie L. Welch, et al.. (2019). Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension. Genome Medicine. 11(1). 69–69. 71 indexed citations

Qiang, Li, Ning Kon, Wenhui Zhao, et al.. (2015). Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions. Cell Reports. 11(11). 1797–1808. 21 indexed citations

Ishibashi, Minako, Scott Sayers, Jeanine D’Armiento, Alan R. Tall, & Carrie L. Welch. (2013). TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques. Atherosclerosis. 229(1). 52–61. 33 indexed citations

Tsuchiya, Kyoichiro, Jun Tanaka, Shuiqing Yu, et al.. (2012). FoxOs Integrate Pleiotropic Actions of Insulin in Vascular Endothelium to Protect Mice from Atherosclerosis. Cell Metabolism. 15(3). 372–381. 135 indexed citations

Qiang, Li, et al.. (2012). Increased Atherosclerosis and Endothelial Dysfunction in Mice Bearing Constitutively Deacetylated Alleles of Foxo1 Gene. Journal of Biological Chemistry. 287(17). 13944–13951. 38 indexed citations

Welch, Carrie L.. (2012). Beyond Genome-Wide Association Studies. Arteriosclerosis Thrombosis and Vascular Biology. 32(2). 207–215. 4 indexed citations

10.

Yvan‐Charvet, Laurent, Tamara A. Pagler, Emmanuel L. Gautier, et al.. (2010). ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation. Science. 328(5986). 1689–1693. 562 indexed citations breakdown →

11.

Ishibashi, Minako, David Masson, Marit Westerterp, et al.. (2010). Reduced VLDL clearance in ApoeNpc1 mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels. Journal of Lipid Research. 51(9). 2655–2663. 10 indexed citations

12.

Han, Seongah, Chien-Ping Liang, Marit Westerterp, et al.. (2009). Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. Journal of Clinical Investigation. 119(4). 1029–41. 74 indexed citations

13.

Yvan‐Charvet, Laurent, Carrie L. Welch, Tamara A. Pagler, et al.. (2008). Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages. Circulation. 118(18). 1837–1847. 365 indexed citations

14.

Welch, Carrie L., Yu Sun, Brian J. Arey, et al.. (2007). Spontaneous Atherothrombosis and Medial Degradation in Apoe ^−/− , Npc1 ^−/− Mice. Circulation. 116(21). 2444–2452. 31 indexed citations

15.

Welch, Carrie L., et al.. (2007). MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 26(34). 5017–5022. 648 indexed citations breakdown →

16.

Klingenspor, Martin, Ping Xu, R. D. Cohen, Carrie L. Welch, & Karen Reue. (1999). Altered Gene Expression Pattern in the Fatty Liver Dystrophy Mouse Reveals Impaired Insulin-mediated Cytoskeleton Dynamics. Journal of Biological Chemistry. 274(33). 23078–23084. 27 indexed citations

17.

Tall, Alan R., Carrie L. Welch, Deborah Applebaum‐Bowden, & Momtaz K. Wassef. (1997). Interaction of Diet and Genes in Atherogenesis Report of an NHLBI Working Group. Arteriosclerosis Thrombosis and Vascular Biology. 17(11). 3326–3331. 20 indexed citations

18.

Ivandic, Boris, et al.. (1997). Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism.. Journal of Clinical Investigation. 99(6). 1406–1419. 117 indexed citations

19.

Xia, Yu, Carrie L. Welch, Craig H. Warden, et al.. (1996). Assignment of the mouse ataxia-telangiectasia gene (Atm) to mouse Chromosome 9. Mammalian Genome. 7(7). 554–555. 5 indexed citations

20.

Welch, Carrie L., L. Wuarin, & Neil Sidell. (1992). Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro. Cancer Letters. 63(3). 211–219. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact